糖尿病视网膜病变的治疗进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
谭晓佳,刘 冀
文章摘要
糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病(diabetes mellitus,DM)的一种微血管并发症,同时也是世界范围内导致失明的主要原因之一。DR作为糖尿病患者的主要致盲因素,绝大多数DR患者的视力无法得到改善,这导致糖尿病视网膜病变的患者生活质量严重下降。虽然目前关于糖尿病视网膜病变的治疗形式较为多样,但由于疾病的特性,致使该病的中晚期疗效难以达到预期,因此,迫切需要开发新的、有效的治疗DR的方法。本文将对当前DR的治疗方案及可能的治疗靶点进行综述和展望。
文章关键词
糖尿病;糖尿病视网膜病变;治疗进展
参考文献
[1] Teo Z L,Tham Y C,Yu M,et al.Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045[J].Ophthalmology, 2021,128(11):1580-1591. [2] Kusuhara S,Fukushima Y,Ogura S,et al.Pathophysiology of Diabetic Retinopathy:The Old and the New[J].Diabetes&Metabolism Journal,2018,42(5):364. [3] Mrugacz M,Bryl A,Falkowski M,et al.Integrins:An important link between angiogenesis,inflammation and eye diseases[J].Cells, 2021,10(7):1703. [4] Yu-Yu C J X W.Effects of panretinal photocoagulation on retinal nerve fiber layer and macular retina in patients with diabetic re ti nopathy[J].2015. [5] Gross J G,Glassman A R,Liu D,et al.Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy:A randomized clinical trial[J].JAMA Ophthalmology,2018,136(10):1138. [6] 李爽,张海召,姜晓丹,等.玻璃体腔注射阿柏西普联合全视网膜光凝治疗糖尿病视网膜病变增殖期黄斑水肿的疗效分析[J].河北医科大学学报,2022,43(2):183-186+197. [7] Giridhar S,Verma L,Rajendran A,et al.Diabetic macular edema treatment guidelines in India:All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement[J].Indian Journal of Ophthalmology,2021, 69(11):3076-3086. [8] Ranno S,Vujosevic S,Mambretti M,et al.Role of vitrectomy in nontractional refractory diabetic macular edema[J].Journal of Clinical Medicine,2023,12(6):2297. [9] Schreur V,Brouwers J,Van Huet R A C,et al.Long‐term outcomes of vitrectomy for proliferative diabetic retinopathy[J].Acta Ophthalmologica,2021,99(1):83-89. [10] Tham Y C,Liu L,Rim T H,et al.Association of cataract surgery with risk of diabetic retinopathy among asian participants in the singapore epidemiology of eye diseases study[J].JAMA Network Open,2020,3(6):e208035. [11] Peng Y,Hu L,Xu H,et al.Resveratrol alleviates reactive oxygen species and inflammation in diabetic retinopathy via SIRT1/HMGB1 pathway-mediated ferroptosis[J].Toxicology and Applied Pharmacology,2025,495:117214. [12] Zhang Y,Pan T,Yang Y,et al.Oridonin attenuates diabetic retinopathy progression by suppressing NLRP3 inflammasome pathway[J]. Molecular and Cellular Endocrinology,2025,596:112419. [13] Sugasini D,Yalagala P C R,Park J C,et al.Retinal docosahexaenoic acid is significantly reduced in diabetic humans and mice:Possible relationship to diabetic retinopathy[J].Investigative Ophthalmology&Visual Science,2024,65(14):39. [14] Sugasini D,Yalagala P,Subbaiah P.Efficient enrichment of retinal DHA with dietary lysophosphatidylcholine-DHA:potential application for retinopathies[J].Nutrients,2020,12(10):3114. [15] Varughese M S,Nayak A U,Jacob S.PCSK9 levels and diabetic retinopathy:opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia[J].Eye,2025,39(4):628-630. [16] Zhou Q,Tang H,Li S.Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions[J]. Journal of Diabetes and Its Complications,2023,37(10):108593. [17] Chen S,Zhang M,Yang P,et al.Genetic association between lipid-regulating drug targets and diabetic retinopathy:a drug target mendelian randomization study[J].Journal of Lipids,2024,2024:1-10. [18] Varughese M S,Nayak A U,Jacob S.Fenofibrate therapy in reducing the progression of diabetic retinopathy:Revisiting the FIELD and ACCORD-EYE studies through the LENS trial[J].Eye,2025,39(1):15-17. [19] Magupalli V G,Negro R,Tian Y,et al.HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation[J].Science,2020,369(6510):eaas8995. [20] Kim J S,Jun J H,Lee J,et al.HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy[J]. Metabolism,2025,164:156108. [21] Huang Y,Zhang Y,Liu Y,et al.PRDX4 mitigates diabetic retinopathy by inhibiting reactive gliosis,apoptosis,ER stress,oxidative stress,and mitochondrial dysfunction in müller cells[J]. Journal of Biological Chemistry,2025,301(1):108111.
Full Text:
DOI